California Texas Louisiana New York Iowa Oregon Nebraska Missouri Washington Ohio Colorado Tennessee Pennsylvania Florida Alabama North Carolina South Carolina Arkansas Kentucky Oklahoma Michigan Indiana Illinois Virginia Massachusetts Maryland Nevada Minnesota Arizona Alaska New Mexico Mississippi Wisconsin Kansas Georgia Maine Montana West Virginia Vermont North Dakota Utah Wyoming South Dakota Idaho RH

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2568 blog entries.

Maryland

The Prescription Drug Affordability Board published a notice that they will be holding two Zoom informational hearings on September 3 to receive input, information and opinions from the public and stakeholders to assist the Board in developing policy to address the affordability challenges created by the use of Farxiga and Jardiance. Details are available in the notice.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Also in Maryland, on August 27, the Insurance Administration (MIA) and Medicaid hosted the inaugural meeting of a workgroup to study PBM practices in both Medicaid and the commercial market. NACDS is serving on the panel, which already has four meetings scheduled for this fall. The department leads presented slides outlining the workgroup composition, schedule, expectations, goals and timeline.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-08-29T12:10:37-04:00August 29, 2025|Maryland|

Massachusetts

In this month’s Pharmacy Facts, published by MassHealth, they provided an update to the vaccine administration fee.

In accordance with 101 CMR 317.03(5): Allowable Fee for Certain Eligible Providers, payment for services provided by pharmacies that utilize pharmacists, or other health care professionals certified in accordance with 105 CMR 700.00: Implementation of M.G.L. c. 94C, is 85% of the allowable fee set forth in 101 CMR 317.04: Maximum Allowable Fees – Medical Services.

Following the pricing methodology cited above, for pharmacies that utilize pharmacists, or other health care professionals certified in accordance with 105 CMR 700.00: Implementation of M.G.L. c. 94C, the administration fee for vaccines other than COVID-19 is $17.38. The administration fee for COVID-19 vaccines is $38.21. Starting August 22, these rates were reflected on all such claims.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2025-08-29T12:09:59-04:00August 29, 2025|Massachusetts|

New York

On August 21, NYRx, the New York State Medicaid Prescription Drug Program, announced an update to its Preferred Drug Program (PDP).

Also in New York, the State Department of Health Office of Health Insurance Programs released a Medicaid update. This update includes a reminder of 90-day prescriptions for most maintenance medications and OTC drugs. The update also includes a notice that NYRx now accepts electronic prior authorizations through CoverMyMeds.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2025-08-29T12:09:24-04:00August 29, 2025|New York|

Alaska

The Board of Pharmacy’s next quarterly meeting will be held virtually only on August 21. The Zoom log-in information, tentative agenda and public meeting packet are available on the board’s webpage. The public will need to register in advance using the link provided on the agenda. If you plan to testify on a subject, you must select “yes” in the questions when registering.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-08-15T11:12:47-04:00August 15, 2025|Alaska|

California

The Department of Health Care Service posted the following alert on the Medi-Cal Rx Web Portal: Now Active: Changes to Remittance Advice. 

Also in California, continuing collaborative efforts, the Board of Pharmacy and the Veterinary Medical Board are working to schedule a forum for stakeholder engagement to discuss crosscutting issues. To ensure interested stakeholders are kept apprised of these efforts, the Board is establishing an interested parties list. Please email rxwebmaster@dca.ca.gov to be added to the email distribution list specific to this forum. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-08-15T11:12:24-04:00August 15, 2025|California|

Florida

House Speaker Danny Perez (R) has invited lawmakers to join a committee to examine potential mid-decade redistricting. Perez said the House lacks the time and resources to hold a special session but wants the committee to convene in October during the scheduled interim committee meeting period. 

Also in Florida, Attorney General James Uthmeier (R) has issued an emergency rule prohibiting 7-OH, a concentrated byproduct of kratom. Physicians caution that the substance is as addictive as opioids. Joining Uthmeier for the announcement, FDA Commissioner Mark Makary warned that kratom could signal the fourth wave of the opioid epidemic. 

Finally, the Department of Revenue has released Tax Information Publication (TIP), titled "Sales Tax on Commercial Rentals Repealed Effective October 1, 2025." Effective October 1, the state sales tax imposed on rent or license fees for the use of real property (commercial rentals) under section 212.031, Florida Statutes (F.S.), is repealed. This means no state sales tax or discretionary sales surtax applies to rent or license fees for rental or occupancy periods beginning on or after October 1, 2025. Examples of commercial rentals subject to the repeal include rentals of commercial office or retail space, warehouses and self-storage units. This publication provides important guidance regarding the upcoming repeal of sales tax on commercial rentals. We encourage you to review the TIP for details on how this change may affect your business or operations. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2025-08-15T11:11:58-04:00August 15, 2025|Florida|

Indiana

The Health Coverage Programs (IHCP) posted several important provider bulletins of interest to pharmacies: 

  • BT2025117 – Pharmacy updates approved by the Office of Medicaid Policy and Planning August 2025 on Ordering, Prescribing or Referring; Pharmacy/Prescribing, Physician/Practitioner 
  • BT2025112 – Pharmacy updates approved by Drug Utilization Review Board July 2025 
  • BT2025107 – Final Notice: Gainwell mail forwarding expired on August 1, 2025 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-08-15T11:11:08-04:00August 15, 2025|Indiana|

Kentucky

The Cabinet for Heath and Family Services released an extremely positive, in-depth report on parity in pharmacy payment for services. The report is a result of SJR 46, legislation adopted in 2025 that NACDS supported. The report found that paying pharmacies for clinical services would have minimal costs and positively impact access to care. As a result, NACDS intends to work with in-state partners to pass legislation mandating Medicaid payment for services in 2026. 

Also in Kentucky, MedImpact issued an updated list of covered influenza vaccines, effective August 16. As a reminder, MedImpact does not require pharmacies to enroll in the Vaccines for Children program to be eligible for reimbursement.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-08-15T11:10:34-04:00August 15, 2025|Kentucky|

Louisiana

The Department of Health (LDH) published several bulletins of interest for pharmacies: 

Also in Louisiana, LDH shared the slide deck from the July Medicaid PBM transition virtual meeting. 

Also in Louisiana, in 2024, Act 711 of 2024 (R.S. 37:1218.2) became law, enabling pharmacists to independently dispense and/or administer HIV PrEP and PEP medications and order/interpret related rapid or laboratory testing. LDH posted the information about the statewide protocol, standing order, guidelines and training resources. 

Finally in Louisiana, the Board of Pharmacy posted the August 20 meeting agenda. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-08-15T11:10:07-04:00August 15, 2025|Louisiana|
Go to Top